Dataset from Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.
应用场景：
创建时间：
2026-02-05
相关数据集
The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF)
Literature suggests that different risks of mortality could influence physicians in prescribing or not anticoagulants in older patients with atrial fibrillation (AF). The Multidimensional Prognostic I
NIAID Data Ecosystem50
Supplementary Material for: Half-dose anticoagulation versus antiplatelet therapy to reduce silent cerebral embolism after left atrial appendage occlusion (HALO-SCE study): Rationale and design of a randomized clinical trial
Introduction: Patients with atrial fibrillation (AF) continue to face thrombotic risks even after the left atrial appendages (LAA) have been occluded, which may manifest as silent cerebral embolisms (
Figshare2025-07-14 更新20
Datasheet1_Designing for patient decision-making: Design challenges generated by patients with atrial fibrillation during evaluation of a decision aid prototype.pdf
Shared decision-making (SDM) empowers patients and care teams to determine the best treatment plan in alignment with the patient's preferences and goals. Decision aids are proven tools to support high
NIAID Data Ecosystem20
Data_Sheet_1_Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study.DOCX
BackgroundSince non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation monitoring, concerns of lower adherence and persistence to NOACs than vitamin K antagonists (VKAs) have
NIAID Data Ecosystem40
Dataset from A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
This is a study in adults with chronic heart failure. People with chronic heart failure may need to be hospitalised for their condition. Some people with chronic heart failure may eventually die fro
NIAID Data Ecosystem20
